BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20087632)

  • 1. Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.
    Bechet D; Tirand L; Faivre B; Plénat F; Bonnet C; Bastogne T; Frochot C; Guillemin F; Barberi-Heyob M
    Pharm Res; 2010 Mar; 27(3):468-79. PubMed ID: 20087632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.
    Tirand L; Thomas N; Dodeller M; Dumas D; Frochot C; Maunit B; Guillemin F; Barberi-Heyob M
    Drug Metab Dispos; 2007 May; 35(5):806-13. PubMed ID: 17283031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
    J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.
    Thomas N; Tirand L; Chatelut E; Plénat F; Frochot C; Dodeller M; Guillemin F; Barberi-Heyob M
    Photochem Photobiol Sci; 2008 Apr; 7(4):433-41. PubMed ID: 18385885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
    Thomas N; Bechet D; Becuwe P; Tirand L; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
    J Photochem Photobiol B; 2009 Aug; 96(2):101-8. PubMed ID: 19464192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.
    Thomas N; Pernot M; Vanderesse R; Becuwe P; Kamarulzaman E; Da Silva D; François A; Frochot C; Guillemin F; Barberi-Heyob M
    Biochem Pharmacol; 2010 Jul; 80(2):226-35. PubMed ID: 20380812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
    Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
    Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.
    Chen B; Pogue BW; Luna JM; Hardman RL; Hoopes PJ; Hasan T
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):917-23. PubMed ID: 16467106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.
    Duanmu J; Cheng J; Xu J; Booth CJ; Hu Z
    Br J Cancer; 2011 Apr; 104(9):1401-9. PubMed ID: 21427724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions.
    Tirand L; Bastogne T; Bechet D; Linder M; Thomas N; Frochot C; Guillemin F; Barberi-Heyob M
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):244-52. PubMed ID: 19604651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.
    Li XY; Yan N; Wu YY; Kong RJ; Qiu ZW; Liu SP; Wu DH; Cheng H
    ACS Appl Mater Interfaces; 2024 May; 16(17):21709-21721. PubMed ID: 38651381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
    Hu Z; Rao B; Chen S; Duanmu J
    BMC Cancer; 2010 May; 10():235. PubMed ID: 20504328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.
    Acker G; Palumbo A; Neri D; Vajkoczy P; Czabanka M
    J Neurooncol; 2016 Aug; 129(1):33-8. PubMed ID: 27188647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of novel procoagulant protein targeting neuropilin-1 on tumour vasculature for tumour embolization therapy.
    Zou M; Samiullah M; Xu P; Wang S; He J; Wu T; Luo F; Yan J
    J Drug Target; 2019 Sep; 27(8):885-895. PubMed ID: 30628471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
    Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
    Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy.
    He C; Agharkar P; Chen B
    Pharm Res; 2008 Aug; 25(8):1873-80. PubMed ID: 18446275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma.
    Li PX; Mu JH; Xiao HL; Li DH
    Oncol Rep; 2015 Jan; 33(1):125-32. PubMed ID: 25376180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silylation improves the photodynamic activity of tetraphenylporphyrin derivatives in vitro and in vivo.
    Horiuchi H; Hosaka M; Mashio H; Terata M; Ishida S; Kyushin S; Okutsu T; Takeuchi T; Hiratsuka H
    Chemistry; 2014 May; 20(20):6054-60. PubMed ID: 24710805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A charge-switchable, four-armed polymeric photosensitizer for photodynamic cancer therapy.
    Lee CS; Park W; Jo YU; Na K
    Chem Commun (Camb); 2014 Apr; 50(33):4354-7. PubMed ID: 24643769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI.
    Bechet D; Auger F; Couleaud P; Marty E; Ravasi L; Durieux N; Bonnet C; Plénat F; Frochot C; Mordon S; Tillement O; Vanderesse R; Lux F; Perriat P; Guillemin F; Barberi-Heyob M
    Nanomedicine; 2015 Apr; 11(3):657-70. PubMed ID: 25645959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.